THE EVOLVING ROLE OF PROTEASOME INHIBITORS IN CANCER TREATMENT
Recent developments in tumor immunology have led to a shift from chemotherapy to targeted therapy, focusing on blocking the pathways that drive cancer. An important aspect of this approach is the personalization of treatment, as the same cancer can present different immunopathologies in different in...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Hematology, Transfusion and Cell Therapy |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2531137924029572 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|